127 related articles for article (PubMed ID: 25361959)
1. Statins and nitric oxide donors affect thrombospondin 1-induced chemotaxis.
Seymour K; Stein J; Han X; Maier KG; Gahtan V
Vasc Endovascular Surg; 2014; 48(7-8):470-5. PubMed ID: 25361959
[TBL] [Abstract][Full Text] [Related]
2. Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis.
Esemuede N; Lee T; Maier KG; Sumpio BE; Gahtan V
J Surg Res; 2011 Jun; 168(1):149-54. PubMed ID: 20338582
[TBL] [Abstract][Full Text] [Related]
3. Dyslipidemia regulates thrombospondin-1-induced vascular smooth muscle cell chemotaxis.
Desai P; Stein JJ; Siddiqui SA; Maier KG; Gahtan V
Mol Cell Biochem; 2015 Dec; 410(1-2):85-91. PubMed ID: 26350564
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of nitric oxide on thrombospondin-1-, PDGF- and fibronectin-induced migration of vascular smooth muscle cells.
Seymour K; Han X; Sadowitz B; Maier KG; Gahtan V
Am J Surg; 2010 Nov; 200(5):615-9. PubMed ID: 21056139
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses.
Isenberg JS; Wink DA; Roberts DD
Cardiovasc Res; 2006 Sep; 71(4):785-93. PubMed ID: 16820142
[TBL] [Abstract][Full Text] [Related]
6. The effects of nicotine on vascular smooth muscle cell chemotaxis induced by thrombospondin-1 and fibronectin.
Stein JJ; Seymour KA; Maier KG; Gahtan V
Am J Surg; 2011 Nov; 202(5):545-8. PubMed ID: 21944292
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of phosphatidylinositol 3-kinase and protein kinase C attenuates extracellular matrix protein-induced vascular smooth muscle cell chemotaxis.
Willis AI; Fuse S; Wang XJ; Chen E; Tuszynski GP; Sumpio BE; Gahtan V
J Vasc Surg; 2000 Jun; 31(6):1160-7. PubMed ID: 10842153
[TBL] [Abstract][Full Text] [Related]
8. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin 1, fibronectin, and vitronectin are differentially dependent upon RAS, ERK1/2, and p38 for induction of vascular smooth muscle cell chemotaxis.
Willis AI; Sadowitz B; Fuse S; Maier KG; Lee TS; Wang XJ; Tuszynski GP; Sumpio BE; Gahtan V
Vasc Endovascular Surg; 2011 Jan; 45(1):55-62. PubMed ID: 21193465
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology.
Helkin A; Maier KG; Gahtan V
Biochem Biophys Res Commun; 2015 Sep; 464(4):1022-1027. PubMed ID: 26168731
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-1 regulation of smooth muscle cell chemotaxis is extracellular signal-regulated protein kinases 1/2 dependent.
Gahtan V; Wang XJ; Willis AI; Tuszynski GP; Sumpio BE
Surgery; 1999 Aug; 126(2):203-7. PubMed ID: 10455885
[TBL] [Abstract][Full Text] [Related]
12. Internal mammary artery smooth muscle cells resist migration and possess high antioxidant capacity.
Mahadevan VS; Campbell M; McKeown PP; Bayraktutan U
Cardiovasc Res; 2006 Oct; 72(1):60-8. PubMed ID: 16860294
[TBL] [Abstract][Full Text] [Related]
13. Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite.
Huang J; Lin SC; Nadershahi A; Watts SW; Sarkar R
J Vasc Surg; 2008 Mar; 47(3):599-607. PubMed ID: 18295111
[TBL] [Abstract][Full Text] [Related]
14. Short-term pravastatin mediates growth inhibition and apoptosis, independently of Ras, via the signaling proteins p27Kip1 and P13 kinase.
Weiss RH; Ramirez A; Joo A
J Am Soc Nephrol; 1999 Sep; 10(9):1880-90. PubMed ID: 10477139
[TBL] [Abstract][Full Text] [Related]
15. Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome.
Ahanchi SS; Varu VN; Tsihlis ND; Martinez J; Pearce CG; Kapadia MR; Jiang Q; Saavedra JE; Keefer LK; Hrabie JA; Kibbe MR
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2388-98. PubMed ID: 18931034
[TBL] [Abstract][Full Text] [Related]
16. Exogenous nitric oxide upregulates p21(waf1/cip1) in pulmonary microvascular smooth muscle cells.
Stotz WH; Li D; Johns RA
J Vasc Res; 2004; 41(3):211-9. PubMed ID: 15051933
[TBL] [Abstract][Full Text] [Related]
17. The C-terminal domain of thrombospondin-1 induces vascular smooth muscle cell chemotaxis.
Nesselroth SM; Willis AI; Fuse S; Olson ET; Lawler J; Sumpio BE; Gahtan V
J Vasc Surg; 2001 Mar; 33(3):595-600. PubMed ID: 11241132
[TBL] [Abstract][Full Text] [Related]
18. The effect of six different statins on the proliferation, migration, and invasion of human smooth muscle cells.
Corpataux JM; Naik J; Porter KE; London NJ
J Surg Res; 2005 Nov; 129(1):52-6. PubMed ID: 16087194
[TBL] [Abstract][Full Text] [Related]
19. The role of G proteins in thromospondin-1-induced vascular smooth muscle cell migration.
Fuse S; Esemuede N; Yamaguchi M; Maier KG; Nesselroth SM; Sumpio BE; Gahtan V
Surgery; 2008 Jul; 144(1):86-92. PubMed ID: 18571589
[TBL] [Abstract][Full Text] [Related]
20. Thrombospondin-1-induced smooth muscle cell chemotaxis and proliferation are dependent on transforming growth factor-β2 and hyaluronic acid synthase.
Stein JJ; Iwuchukwu C; Maier KG; Gahtan V
Mol Cell Biochem; 2013 Dec; 384(1-2):181-6. PubMed ID: 24104451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
